Mangoceuticals Overview
Latest P/E ratio for Mangoceuticals: -0.32 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-0.32
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Mangoceuticals (MGRX) currently reports a P/E ratio of -0.32. That is below the sector sector average of 44.85. Use the charts on this page to explore Mangoceuticals's P/E ratio history and peer comparisons.
Mangoceuticals's P/E ratio of -0.32 is lower than the its sector sector average of 44.85. That is roughly 100.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Mangoceuticals's market price to a fundamental measure such as earnings, sales, or book value. At -0.32, MGRX can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -0.32, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 44.85. From there, open related valuation or income-statement pages for Mangoceuticals, and consider following MGRX for alerts when major investors trade the stock.
